Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Statement of Changes in Stockholders' Deficit

v3.20.2
Condensed Consolidated Statement of Changes in Stockholders' Deficit - USD ($)
Common Stock [Member]
Additional Paid-In-Capital [Member]
Accumulated Deficit [Member]
Total
Balance at Dec. 31, 2018 $ 670 $ 58,407,257 $ (61,943,318) $ (3,535,391)
Balance, shares at Dec. 31, 2018 669,967      
Common stock grants to independent directors $ 5 174,995 175,000
Common stock grants to independent directors, shares 5,220      
Common stock grants to service providers 11,062 11,062
Common stock grants to service providers, shares 375      
Stock based compensation - options 173,000 173,000
Restricted stock issuances $ 8 244,992 245,000
Restricted stock issuances, shares 8,169      
Issuance of warrants attached to a convertible note 33,300 33,300
Extinguishment of derivative liability upon repayment of convertible note      
Net loss (2,217,114) (2,217,114)
Balance at Jun. 30, 2019 $ 683 59,044,605 (64,160,432) (5,115,143)
Balance, shares at Jun. 30, 2019 683,731      
Balance at Mar. 31, 2019 $ 674 58,632,628 (63,078,738) (4,445,436)
Balance, shares at Mar. 31, 2019 673,958      
Common stock grants to independent directors $ 3 87,497 87,500
Common stock grants to independent directors, shares 2,917      
Common stock grants to service providers 4,687 4,687
Common stock grants to service providers, shares 188      
Stock based compensation - options 86,500 86,500
Restricted stock issuances $ 7 199,993 200,000
Restricted stock issuances, shares 6,668      
Issuance of warrants attached to a convertible note 33,300 33,300
Net loss (1,081,694) (1,081,694)
Balance at Jun. 30, 2019 $ 683 59,044,605 (64,160,432) (5,115,143)
Balance, shares at Jun. 30, 2019 683,731      
Balance at Dec. 31, 2019 $ 688 59,836,818 (67,036,355) (7,198,849)
Balance, shares at Dec. 31, 2019 687,564      
Common stock grants to independent directors $ 11 37,489 37,500
Common stock grants to independent directors, shares 11,458      
Stock based compensation - options 156,875 156,875
Issuance of warrants attached to a convertible note 2,777 2,777
Warrants granted to independent directors 150,000 150,000
Common stock grant to convertible note holders $ 81 532,131 532,212
Common stock grant to convertible note holders, shares 81,409      
Beneficial conversion feature issued on convertible notes 141,391 141,391
Revaluation of notes payable discounts due to modification of conversion price (214,498) (214,498)
Extinguishment of derivative liability upon repayment of convertible note 458,977 458,977
Stock retirement $ (27) 27
Stock retirement, shares (27,777)      
Net loss (2,703,210) (2,703,210)
Balance at Jun. 30, 2020 $ 753 61,101,987 (69,739,565) (8,636,825)
Balance, shares at Jun. 30, 2020 752,654      
Balance at Mar. 31, 2020 $ 762 60,457,139 (68,039,223) (7,581,322)
Balance, shares at Mar. 31, 2020 762,098      
Common stock grants to independent directors $ 8 18,742 18,750
Common stock grants to independent directors, shares 8,333      
Stock based compensation - options 72,812 72,812
Warrants granted to independent directors 75,000 75,000
Common stock grant to convertible note holders $ 10 97,490 97,500
Common stock grant to convertible note holders, shares 10,000      
Extinguishment of derivative liability upon repayment of convertible note 380,777 380,777
Stock retirement $ (27) 27
Stock retirement, shares (27,777)      
Net loss     (1,700,342) (1,700,342)
Balance at Jun. 30, 2020 $ 753 $ 61,101,987 $ (69,739,565) $ (8,636,825)
Balance, shares at Jun. 30, 2020 752,654